Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.
about
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyThe Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet TherapyP2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cellsResistance to antiplatelet drugs: current status and future researchBiological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteersPlasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjectsEvidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'Clopidogrel resistance: myth or reality?Antiplatelet therapy in populations at high risk of atherothrombosisImpact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgeryAnother "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.Correlations between High Platelet Reactivity, Extent of Coronary Artery Disease, and Periprocedural Myonecrosis in Patients with Acute Coronary SyndromePlatelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational studyA pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCIAspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Drug-drug interaction between clopidogrel and the proton pump inhibitors.Platelet function tests: a comparative review.Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort studyNew highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptorsP2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery diseaseComparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome.Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the WoInverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Personalized antiplatelet therapy for coronary artery disease patients: is this the future?Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.Clopidogrel in acute coronary syndrome: implications of recent study findings.Resistance to aspirin and clopidogrel therapy.Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management.Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.Advances in the monitoring of anti-P2Y12 therapy.P2Y12 receptor: platelet thrombus formation and medical interventions.Platelet function monitoring and clopidogrel.
P2860
Q24629255-7B5CD328-A21E-4006-88F5-C3CC8D3B6B1CQ26801874-4214AAE8-64F5-4176-863C-4AF06E6E0B3BQ26861200-64964ADA-BF42-49E7-8AFC-98F9DE8B5C09Q28192298-F0F9081D-8677-4A67-A803-EE6F4A5D3551Q28196714-8AD91617-EEC3-47B4-96F0-E2326F6FFCDDQ28200541-75B2218B-0BFA-49EC-9AC5-FD00E4F7C672Q28200552-FC3E019A-7D7E-410C-A820-84645C03C304Q28218055-03B0B9B0-32FD-4045-823C-39A5994F4B00Q28218702-BCE0766C-6D97-4E3D-977D-1DFB64EB4A71Q28542407-1B1EDEA2-0CD3-4B54-B747-E67C0E7C8A2BQ28543952-C791C1F0-8B2F-4162-A014-4CFEA1E51479Q30373414-B397EFD4-67B6-4921-83CD-F46453F37AA4Q30450312-AE6D0F7D-3FB8-4FC8-9E13-CBF2C796B36CQ30498026-B2D3EB04-A223-4FD7-8F49-D1AAA1F43BE2Q33636020-8FA3EA88-5761-45E8-88DC-2D87C37252C9Q33760816-8B353BB5-279C-4194-ADB9-71E8EE015E7FQ34325757-D2703622-6EC7-478C-8254-E2E636DC4959Q34761979-97CE3B9A-69A8-4C0A-B83C-5BD984284E80Q34771381-56E2938F-7BAD-4AF1-A1B8-0F906BAFF23BQ34983154-F2F46F2B-5A65-441B-B6B9-CDA41466A983Q35121464-8053BCCF-0D95-43CE-A75A-8F16BC453E70Q36045746-163C224A-0263-4E1A-A5AB-B9361594C00AQ36359617-73E73242-D88E-4098-B0EC-1DA8034171F4Q36536498-A276CA04-B95C-4660-8C88-94897CF536CDQ36976793-CB17A42F-B61C-4B59-BD28-78D3915F536DQ37203987-E89ECC6E-B2CC-49FE-A924-080482322120Q37378896-7B1095C6-6EEF-4961-A4EC-0387C7CBCC67Q37509443-554952EE-7B1E-4020-8AD8-05753D0749B6Q37540088-35BC906B-5D39-45CB-9774-B90639734D7CQ37562606-668DC1BF-D266-420D-A331-DC11092A98F9Q37629641-65492D87-E5AD-4C54-9AC9-8F83F07779EFQ37642822-9FEE5973-0493-416D-B573-CCEDBD71C6C8Q37752222-F1A8F139-E1C4-4387-B74C-82809181D25FQ37786639-D75B8BDD-CDBA-40CC-A7F9-6CCB8B25FB1DQ37807524-92C3DAE9-B36E-447E-81D1-C105AB51313FQ37809122-AEA86A09-05DD-4325-9F1D-D71B985CBCA2Q37841560-10CFC54D-9D27-4795-A6B7-DCD60F637845Q38037121-A5ADC8BC-2AC2-4EC8-9D78-56CBC36B452AQ38051192-92EED0E2-3000-4628-99D3-CF54B3008F7DQ38068348-30E7D411-5ED4-4243-B2DE-66C06571F92E
P2860
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@en
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@nl
type
label
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@en
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@nl
prefLabel
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@en
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@nl
P2093
P2860
P921
P1476
Flow cytometric analysis of in ...... hemic cardiovascular diseases.
@en
P2093
P2860
P356
10.1111/J.1538-7836.2004.01063.X
P577
2005-01-01T00:00:00Z